|
Analogs
-
11616941
-
-
11616943
-
-
27079413
-
-
43771549
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ADA17-1-E |
ADAM17 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.50 |
Binding ≤ 10μM
|
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.51 |
Binding ≤ 10μM
|
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.51 |
Binding ≤ 10μM
|
MMP13-1-E |
Matrix Metalloproteinase 13 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
4 |
0.51 |
Binding ≤ 10μM
|
MMP14-3-E |
Matrix Metalloproteinase 14 (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
2 |
0.53 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.50 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.50 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
84 |
0.43 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
200 |
0.41 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.51 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.47 |
Binding ≤ 10μM
|
MMP8-1-E |
Matrix Metalloproteinase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.53 |
Binding ≤ 10μM
|
MMP8-1-E |
Matrix Metalloproteinase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.53 |
Binding ≤ 10μM
|
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
3 |
0.52 |
Binding ≤ 10μM
|
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.49 |
Binding ≤ 10μM
|
ADA17-1-E |
ADAM17 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7000 |
0.31 |
Functional ≤ 10μM
|
TNFA-2-E |
TNF-alpha (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
1001 |
0.37 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
4100 |
0.33 |
Functional ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 5), Other |
Other |
2100 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.38 |
0.45 |
-15.72 |
5 |
8 |
0 |
128 |
331.413 |
8 |
↓
|
Hi
High (pH 8-9.5)
|
0.38 |
1.66 |
-56.16 |
4 |
8 |
-1 |
131 |
330.405 |
8 |
↓
|
|
|
Analogs
-
1544157
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.51 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.50 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
200 |
0.41 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.47 |
Binding ≤ 10μM
|
MMP8-1-E |
Matrix Metalloproteinase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.53 |
Binding ≤ 10μM
|
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
3 |
0.52 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.38 |
0.65 |
-22.37 |
5 |
8 |
0 |
128 |
331.413 |
8 |
↓
|
Hi
High (pH 8-9.5)
|
0.38 |
1.88 |
-61.38 |
4 |
8 |
-1 |
131 |
330.405 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP13-4-E |
Matrix Metalloproteinase 13 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
73 |
0.24 |
Binding ≤ 10μM
|
MMP14-1-E |
Matrix Metalloproteinase 14 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1900 |
0.20 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1790 |
0.20 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.28 |
Binding ≤ 10μM
|
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
840 |
0.21 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.37 |
-1.05 |
-17.51 |
4 |
7 |
0 |
107 |
557.735 |
13 |
↓
|
Hi
High (pH 8-9.5)
|
6.55 |
-0.48 |
-57.77 |
3 |
7 |
-1 |
113 |
556.727 |
13 |
↓
|
Hi
High (pH 8-9.5)
|
6.37 |
-0.48 |
-57.77 |
3 |
7 |
-1 |
110 |
556.727 |
13 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CAH2-5-E |
Carbonic Anhydrase II (cluster #5 Of 15), Eukaryotic |
Eukaryotes |
29 |
0.70 |
Binding ≤ 10μM
|
CAH4-1-E |
Carbonic Anhydrase IV (cluster #1 Of 16), Eukaryotic |
Eukaryotes |
40 |
0.69 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
9000 |
0.47 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
10000 |
0.47 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.09 |
-2.76 |
-16.94 |
3 |
6 |
0 |
95 |
230.245 |
3 |
↓
|
Hi
High (pH 8-9.5)
|
-0.09 |
-1.75 |
-56.86 |
2 |
6 |
-1 |
98 |
229.237 |
3 |
↓
|
|
|
Analogs
-
3918087
-
-
3938704
-
-
3995925
-
-
3995927
-
-
3995929
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1900 |
0.21 |
Binding ≤ 10μM
|
Z50460-3-O |
Leishmania Major (cluster #3 Of 4), Other |
Other |
380 |
0.24 |
Functional ≤ 10μM
|
Z80014-1-O |
A204 (Rhabdomyosarcoma Cells) (cluster #1 Of 1), Other |
Other |
3000 |
0.20 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
3000 |
0.20 |
Functional ≤ 10μM |
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
63 |
0.27 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
9 |
0.30 |
Functional ≤ 10μM |
Z80060-1-O |
CAPAN-1 (Pancreatic Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
390 |
0.24 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
390 |
0.24 |
Functional ≤ 10μM |
Z80134-1-O |
EVSA-T (cluster #1 Of 1), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM |
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
5 |
0.31 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
400 |
0.24 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
15 |
0.29 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
7 |
0.30 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
60 |
0.27 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
36 |
0.27 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
1 |
0.33 |
Functional ≤ 10μM |
Z80335-2-O |
NHDF (cluster #2 Of 2), Other |
Other |
404 |
0.24 |
Functional ≤ 10μM |
Z80342-1-O |
NSCLC (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.31 |
Functional ≤ 10μM |
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
390 |
0.24 |
Functional ≤ 10μM |
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
3 |
0.31 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
440 |
0.23 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.23 |
Functional ≤ 10μM |
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
1600 |
0.21 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM |
Z80571-1-O |
UCLA P-3 (cluster #1 Of 1), Other |
Other |
730 |
0.23 |
Functional ≤ 10μM |
Z80585-1-O |
WALKER (cluster #1 Of 1), Other |
Other |
47 |
0.27 |
Functional ≤ 10μM |
Z80606-1-O |
YOSHIDA (Sarcoma Cells) (cluster #1 Of 1), Other |
Other |
7 |
0.30 |
Functional ≤ 10μM |
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.26 |
Functional ≤ 10μM
|
Z80957-1-O |
HMEC (Microvascular Endothelial Cells) (cluster #1 Of 2), Other |
Other |
98 |
0.26 |
Functional ≤ 10μM |
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
7000 |
0.19 |
Functional ≤ 10μM |
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
700 |
0.23 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
380 |
0.24 |
Functional ≤ 10μM |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
83 |
0.26 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
640 |
0.23 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
16 |
0.29 |
Functional ≤ 10μM |
Z81159-1-O |
Lewis Cell Line (cluster #1 Of 1), Other |
Other |
61 |
0.27 |
Functional ≤ 10μM |
Z81227-1-O |
M-19 Cell Line (cluster #1 Of 1), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
977 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
2960 |
0.20 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
250 |
0.24 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
8600 |
0.19 |
Functional ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
880 |
0.22 |
ADME/T ≤ 10μM |
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
2500 |
0.21 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.90 |
1.34 |
-54.26 |
7 |
11 |
1 |
187 |
528.534 |
4 |
↓
|
|
|
Analogs
-
3917708
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103196-1-O |
22RV1 (cluster #1 Of 2), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM |
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2540 |
0.20 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
940 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
4700 |
0.19 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
950 |
0.22 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
430 |
0.23 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
17 |
0.28 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
680 |
0.22 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
3100 |
0.20 |
Functional ≤ 10μM |
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
540 |
0.22 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
6810 |
0.19 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
1290 |
0.21 |
Functional ≤ 10μM |
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
710 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
840 |
0.22 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2320 |
0.20 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.88 |
-58.15 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
-
3830631
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.9 |
-63.19 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
490 |
0.32 |
Binding ≤ 10μM
|
MMP12-1-E |
Macrophage Metalloelastase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
MMP13-3-E |
Matrix Metalloproteinase 13 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
4 |
0.42 |
Binding ≤ 10μM
|
MMP14-2-E |
Matrix Metalloproteinase 14 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
10 |
0.40 |
Binding ≤ 10μM
|
MMP16-1-E |
Matrix Metalloproteinase 16 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
51 |
0.36 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1 |
0.45 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2 |
0.43 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
50 |
0.37 |
Binding ≤ 10μM
|
MMP8-4-E |
Matrix Metalloproteinase 8 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.43 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7 |
0.41 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.64 |
7.24 |
-15.89 |
2 |
7 |
0 |
96 |
406.504 |
8 |
↓
|
Hi
High (pH 8-9.5)
|
3.83 |
5.88 |
-59.91 |
1 |
7 |
-1 |
102 |
405.496 |
8 |
↓
|
Hi
High (pH 8-9.5)
|
3.64 |
8.44 |
-65.01 |
1 |
7 |
-1 |
99 |
405.496 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2 |
0.43 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
10 |
0.40 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
13 |
0.39 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.64 |
7.58 |
-18.04 |
2 |
7 |
0 |
96 |
406.504 |
8 |
↓
|
Hi
High (pH 8-9.5)
|
3.83 |
6.03 |
-53.25 |
1 |
7 |
-1 |
102 |
405.496 |
8 |
↓
|
Hi
High (pH 8-9.5)
|
3.64 |
8.41 |
-58 |
1 |
7 |
-1 |
99 |
405.496 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 6 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2900 |
0.31 |
Binding ≤ 10μM
|
MMP13-3-E |
Matrix Metalloproteinase 13 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
45 |
0.41 |
Binding ≤ 10μM
|
MMP14-2-E |
Matrix Metalloproteinase 14 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
2300 |
0.32 |
Binding ≤ 10μM
|
MMP16-1-E |
Matrix Metalloproteinase 16 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
900 |
0.34 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
13 |
0.44 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5900 |
0.29 |
Binding ≤ 10μM
|
MMP8-3-E |
Matrix Metalloproteinase 8 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
260 |
0.37 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
200 |
0.38 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.53 |
4.59 |
-15.92 |
2 |
7 |
0 |
96 |
364.423 |
7 |
↓
|
Hi
High (pH 8-9.5)
|
2.53 |
5.81 |
-53.13 |
1 |
7 |
-1 |
99 |
363.415 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ADA10-1-E |
ADAM10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.40 |
Binding ≤ 10μM
|
ADA12-1-E |
ADAM12 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.41 |
Binding ≤ 10μM
|
ADA17-1-E |
ADAM17 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8 |
0.40 |
Binding ≤ 10μM
|
ADAM9-1-E |
ADAM9 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
56 |
0.36 |
Binding ≤ 10μM
|
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.41 |
Binding ≤ 10μM
|
MMP10-1-E |
Matrix Metalloproteinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
26 |
0.38 |
Binding ≤ 10μM
|
MMP11-1-E |
Matrix Metalloproteinase 11 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
26 |
0.38 |
Binding ≤ 10μM
|
MMP12-1-E |
Macrophage Metalloelastase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.42 |
Binding ≤ 10μM
|
MMP13-1-E |
Matrix Metalloproteinase 13 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
5 |
0.42 |
Binding ≤ 10μM
|
MMP14-1-E |
Matrix Metalloproteinase 14 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5 |
0.42 |
Binding ≤ 10μM
|
MMP15-1-E |
Matrix Metalloproteinase 15 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.41 |
Binding ≤ 10μM
|
MMP16-1-E |
Matrix Metalloproteinase 16 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.40 |
Binding ≤ 10μM
|
MMP17-1-E |
Matrix Metalloproteinase 17 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.43 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7 |
0.41 |
Binding ≤ 10μM
|
MMP26-1-E |
Matrix Metalloproteinase 26 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
17 |
0.39 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7 |
0.41 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
33 |
0.37 |
Binding ≤ 10μM
|
MMP8-1-E |
Matrix Metalloproteinase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
10 |
0.40 |
Binding ≤ 10μM
|
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
7 |
0.41 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.55 |
3.16 |
-20.09 |
5 |
8 |
0 |
123 |
388.468 |
9 |
↓
|
Hi
High (pH 8-9.5)
|
1.55 |
4.38 |
-63.44 |
4 |
8 |
-1 |
126 |
387.46 |
9 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ADA17-1-E |
ADAM17 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4 |
0.31 |
Binding ≤ 10μM
|
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
21 |
0.28 |
Binding ≤ 10μM
|
MMP10-1-E |
Matrix Metalloproteinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
190 |
0.25 |
Binding ≤ 10μM
|
MMP13-1-E |
Matrix Metalloproteinase 13 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
10 |
0.29 |
Binding ≤ 10μM
|
MMP14-1-E |
Matrix Metalloproteinase 14 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1200 |
0.22 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7 |
0.30 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
660 |
0.23 |
Binding ≤ 10μM
|
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
5 |
0.31 |
Binding ≤ 10μM
|
A4-1-E |
Beta Amyloid A4 Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
200 |
0.25 |
Functional ≤ 10μM
|
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
200 |
0.25 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.41 |
12.04 |
-28.44 |
3 |
8 |
0 |
108 |
523.674 |
12 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP13-2-E |
Matrix Metalloproteinase 13 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
820 |
0.33 |
Binding ≤ 10μM
|
MMP14-2-E |
Matrix Metalloproteinase 14 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
6000 |
0.28 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
980 |
0.32 |
Binding ≤ 10μM
|
MMP8-3-E |
Matrix Metalloproteinase 8 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
260 |
0.35 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7100 |
0.28 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.83 |
5.47 |
-40.47 |
2 |
6 |
-1 |
107 |
396.425 |
8 |
↓
|
Mid
Mid (pH 6-8)
|
2.83 |
6.45 |
-121.43 |
1 |
6 |
-2 |
109 |
395.417 |
8 |
↓
|
|
|
Analogs
-
6116142
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5000 |
0.27 |
Binding ≤ 10μM
|
MMP13-4-E |
Matrix Metalloproteinase 13 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
1470 |
0.29 |
Binding ≤ 10μM
|
MMP13-4-E |
Matrix Metalloproteinase 13 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
1570 |
0.29 |
Binding ≤ 10μM
|
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
11 |
0.40 |
Binding ≤ 10μM
|
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
91 |
0.35 |
Binding ≤ 10μM
|
MMP3-2-E |
Matrix Metalloproteinase 3 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
143 |
0.34 |
Binding ≤ 10μM
|
MMP3-2-E |
Matrix Metalloproteinase 3 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
7950 |
0.25 |
Binding ≤ 10μM
|
MMP8-4-E |
Matrix Metalloproteinase 8 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
303 |
0.33 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
301 |
0.33 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3110 |
0.28 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.88 |
1.92 |
-59.71 |
0 |
3 |
-1 |
57 |
409.914 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
LEF-1-B |
Anthrax Lethal Factor (cluster #1 Of 2), Bacterial |
Bacteria |
1200 |
0.31 |
Binding ≤ 10μM
|
ADA10-1-E |
ADAM10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
890 |
0.31 |
Binding ≤ 10μM
|
ADA17-2-E |
ADAM17 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
41 |
0.38 |
Binding ≤ 10μM
|
BMP1-1-E |
Bone Morphogenetic Protein 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3000 |
0.29 |
Binding ≤ 10μM
|
CAH2-1-E |
Carbonic Anhydrase II (cluster #1 Of 15), Eukaryotic |
Eukaryotes |
8600 |
0.26 |
Binding ≤ 10μM
|
CAH9-1-E |
Carbonic Anhydrase IX (cluster #1 Of 11), Eukaryotic |
Eukaryotes |
7800 |
0.26 |
Binding ≤ 10μM
|
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
96 |
0.36 |
Binding ≤ 10μM
|
MMP12-1-E |
Macrophage Metalloelastase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8 |
0.42 |
Binding ≤ 10μM
|
MMP13-3-E |
Matrix Metalloproteinase 13 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
8 |
0.42 |
Binding ≤ 10μM
|
MMP14-2-E |
Matrix Metalloproteinase 14 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
9 |
0.42 |
Binding ≤ 10μM
|
MMP16-1-E |
Matrix Metalloproteinase 16 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.42 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
15 |
0.41 |
Binding ≤ 10μM
|
MMP25-1-E |
Matrix Metalloproteinase-25 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.45 |
Binding ≤ 10μM |
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7 |
0.42 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
736 |
0.32 |
Binding ≤ 10μM
|
MMP8-1-E |
Matrix Metalloproteinase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
8 |
0.42 |
Binding ≤ 10μM |
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
10 |
0.41 |
Binding ≤ 10μM
|
Z50591-2-O |
Bos Taurus (cluster #2 Of 2), Other |
Other |
50 |
0.38 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.37 |
3.65 |
-24.43 |
2 |
8 |
0 |
109 |
393.465 |
8 |
↓
|
Hi
High (pH 8-9.5)
|
1.55 |
1.28 |
-51.2 |
1 |
8 |
-1 |
115 |
392.457 |
8 |
↓
|
Hi
High (pH 8-9.5)
|
1.37 |
3.89 |
-61.96 |
1 |
8 |
-1 |
112 |
392.457 |
8 |
↓
|
|
|
Analogs
-
34485209
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-3-E |
72 KDa Type IV Collagenase (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
4000 |
0.54 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.03 |
-1.38 |
-124.33 |
4 |
6 |
-1 |
120 |
221.173 |
2 |
↓
|
Lo
Low (pH 4.5-6)
|
-1.03 |
-2.53 |
-71.93 |
5 |
6 |
0 |
117 |
222.181 |
2 |
↓
|
|
|
Analogs
-
11616934
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ADA17-1-E |
ADAM17 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
15 |
0.34 |
Binding ≤ 10μM
|
FCER2-1-E |
Immunoglobulin Epsilon Fc Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
100 |
0.31 |
Binding ≤ 10μM
|
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.36 |
Binding ≤ 10μM
|
MMP13-1-E |
Matrix Metalloproteinase 13 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
5 |
0.36 |
Binding ≤ 10μM
|
MMP14-1-E |
Matrix Metalloproteinase 14 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
47 |
0.32 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4 |
0.37 |
Binding ≤ 10μM |
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
20 |
0.34 |
Binding ≤ 10μM |
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.36 |
Binding ≤ 10μM |
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
25 |
0.33 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.50 |
-4.65 |
-17.84 |
4 |
7 |
0 |
107 |
477.652 |
12 |
↓
|
Hi
High (pH 8-9.5)
|
3.69 |
-4.09 |
-61.6 |
3 |
7 |
-1 |
113 |
476.644 |
12 |
↓
|
|
|
Analogs
-
36984968
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
8000 |
0.36 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.06 |
8.38 |
-46.79 |
0 |
4 |
-1 |
73 |
266.276 |
5 |
↓
|
|
|
Analogs
-
2149993
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
500 |
0.32 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.92 |
8.27 |
-60.54 |
2 |
6 |
-1 |
102 |
393.444 |
6 |
↓
|
|
|
|
|
Analogs
-
26639816
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6500 |
0.30 |
Binding ≤ 10μM
|
MMP13-2-E |
Matrix Metalloproteinase 13 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
48 |
0.43 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
11 |
0.46 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2000 |
0.33 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
9 |
0.47 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7500 |
0.30 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.38 |
7.54 |
-42.93 |
1 |
5 |
-1 |
86 |
366.846 |
6 |
↓
|
|
|
Analogs
-
3978503
-
-
4534390
-
-
4544252
-
-
8681494
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 29 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
6PGD-1-E |
6-phosphogluconate Dehydrogenase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
720 |
0.26 |
Binding ≤ 10μM
|
BCL2-1-E |
Apoptosis Regulator Bcl-2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
234 |
0.28 |
Binding ≤ 10μM
|
ERG1-3-E |
Squalene Monooxygenase (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
690 |
0.26 |
Binding ≤ 10μM
|
KCNH2-1-E |
HERG (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
6026 |
0.22 |
Binding ≤ 10μM
|
MET-1-E |
Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3300 |
0.23 |
Binding ≤ 10μM
|
MK14-2-E |
MAP Kinase P38 Alpha (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
2210 |
0.24 |
Binding ≤ 10μM
|
MMP14-1-E |
Matrix Metalloproteinase 14 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6800 |
0.22 |
Binding ≤ 10μM
|
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
9600 |
0.21 |
Binding ≤ 10μM
|
Q965D5-1-E |
Enoyl-acyl-carrier Protein Reductase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.34 |
Binding ≤ 10μM
|
Q965D6-1-E |
3-oxoacyl-acyl-carrier Protein Reductase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
300 |
0.28 |
Binding ≤ 10μM
|
Q965D7-2-E |
Fatty Acid Synthase (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
400 |
0.27 |
Binding ≤ 10μM
|
G6PD-1-F |
Glucose-6-phosphate 1-dehydrogenase (cluster #1 Of 1), Fungal |
Fungi |
250 |
0.28 |
Binding ≤ 10μM
|
Z50142-1-O |
Influenza A Virus (A/PR/8/34(H1N1)) (cluster #1 Of 2), Other |
Other |
391 |
0.27 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
9900 |
0.21 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
9400 |
0.21 |
Functional ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 6), Viral |
Viruses |
730 |
0.26 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.25 |
-6.71 |
-20.66 |
8 |
11 |
0 |
197 |
458.375 |
4 |
↓
|
Hi
High (pH 8-9.5)
|
2.25 |
-5.81 |
-60.24 |
7 |
11 |
-1 |
200 |
457.367 |
4 |
↓
|
Hi
High (pH 8-9.5)
|
2.25 |
-5.67 |
-56.02 |
7 |
11 |
-1 |
200 |
457.367 |
4 |
↓
|
|
|
Analogs
-
600699
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
7 |
0.37 |
Binding ≤ 10μM |
MMP13-1-E |
Matrix Metalloproteinase 13 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
7 |
0.37 |
Binding ≤ 10μM |
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7 |
0.37 |
Binding ≤ 10μM |
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
527 |
0.28 |
Binding ≤ 10μM |
MMP8-1-E |
Matrix Metalloproteinase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
7 |
0.37 |
Binding ≤ 10μM |
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
7 |
0.37 |
Binding ≤ 10μM |
Z50591-2-O |
Bos Taurus (cluster #2 Of 2), Other |
Other |
100 |
0.32 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.07 |
-1.05 |
-17.22 |
2 |
9 |
0 |
110 |
436.553 |
7 |
↓
|
Hi
High (pH 8-9.5)
|
2.07 |
-0.49 |
-66.15 |
1 |
9 |
-1 |
113 |
435.545 |
7 |
↓
|
|
|
Analogs
-
3871393
-
-
3871392
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
DEF-1-B |
Peptide Deformylase (cluster #1 Of 1), Bacterial |
Bacteria |
5 |
0.43 |
Binding ≤ 10μM
|
Q9JN24-1-B |
Peptide Deformylase (cluster #1 Of 1), Bacterial |
Bacteria |
140 |
0.36 |
Binding ≤ 10μM |
DEF1A-1-E |
Peptide Deformylase 1A, Chloroplastic (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
27 |
0.39 |
Binding ≤ 10μM
|
DEFM-1-E |
Peptide Deformylase Mitochondrial (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
600 |
0.32 |
Binding ≤ 10μM
|
ECE1-1-E |
Endothelin-converting Enzyme 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4000 |
0.28 |
Binding ≤ 10μM
|
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
300 |
0.34 |
Binding ≤ 10μM |
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
1100 |
0.31 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3000 |
0.29 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1700 |
0.30 |
Binding ≤ 10μM |
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6000 |
0.27 |
Binding ≤ 10μM
|
MMP8-1-E |
Matrix Metalloproteinase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
190 |
0.35 |
Binding ≤ 10μM |
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
330 |
0.34 |
Binding ≤ 10μM |
NEP-2-E |
Neprilysin (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
8200 |
0.26 |
Binding ≤ 10μM
|
Z50425-6-O |
Plasmodium Falciparum (cluster #6 Of 22), Other |
Other |
2512 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.51 |
2.32 |
-16.44 |
4 |
8 |
0 |
119 |
385.505 |
11 |
↓
|
Hi
High (pH 8-9.5)
|
1.51 |
3.4 |
-55.95 |
3 |
8 |
-1 |
122 |
384.497 |
11 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.22 |
1.23 |
-22.17 |
2 |
7 |
0 |
96 |
316.379 |
7 |
↓
|
Hi
High (pH 8-9.5)
|
1.22 |
2.41 |
-64.1 |
1 |
7 |
-1 |
99 |
315.371 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
500 |
0.74 |
Binding ≤ 10μM
|
MMP2-3-E |
72 KDa Type IV Collagenase (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
80 |
0.83 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.10 |
-2.45 |
-127.32 |
1 |
5 |
-2 |
92 |
191.123 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
100 |
0.39 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.41 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.76 |
6.23 |
-56.43 |
1 |
6 |
-1 |
96 |
362.427 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
898 |
0.37 |
Binding ≤ 10μM
|
MMP3-2-E |
Matrix Metalloproteinase 3 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
9000 |
0.31 |
Binding ≤ 10μM
|
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
696 |
0.37 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.78 |
2.36 |
-41.31 |
1 |
5 |
-1 |
82 |
307.329 |
3 |
↓
|
Mid
Mid (pH 6-8)
|
2.22 |
2.42 |
-41.38 |
1 |
5 |
-1 |
82 |
307.329 |
3 |
↓
|
Mid
Mid (pH 6-8)
|
2.59 |
4.93 |
-8.44 |
2 |
5 |
0 |
75 |
308.337 |
3 |
↓
|
|
|
Analogs
-
13680271
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6000 |
0.30 |
Binding ≤ 10μM
|
MMP13-2-E |
Matrix Metalloproteinase 13 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
8 |
0.47 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4 |
0.49 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2000 |
0.33 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7 |
0.48 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.30 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7900 |
0.30 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.51 |
7.65 |
-42.79 |
1 |
5 |
-1 |
86 |
411.297 |
6 |
↓
|
|
|
Analogs
-
3961071
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6200 |
0.30 |
Binding ≤ 10μM
|
MMP13-2-E |
Matrix Metalloproteinase 13 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
16 |
0.45 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5 |
0.48 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2000 |
0.33 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.47 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1500 |
0.34 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.51 |
7.48 |
-54.21 |
1 |
5 |
-1 |
86 |
411.297 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2200 |
0.33 |
Binding ≤ 10μM
|
MMP13-4-E |
Matrix Metalloproteinase 13 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
11 |
0.46 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2 |
0.51 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3 |
0.50 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4500 |
0.31 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3900 |
0.32 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.15 |
7.61 |
-46.41 |
1 |
5 |
-1 |
86 |
346.428 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
110 |
0.39 |
Binding ≤ 10μM
|
MMP13-3-E |
Matrix Metalloproteinase 13 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.49 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3 |
0.48 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.45 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
140 |
0.38 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
18 |
0.43 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.51 |
3.96 |
-22.07 |
3 |
6 |
0 |
95 |
427.32 |
6 |
↓
|
Hi
High (pH 8-9.5)
|
3.51 |
5.18 |
-64.2 |
2 |
6 |
-1 |
98 |
426.312 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ADA17-2-E |
ADAM17 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
440 |
0.32 |
Binding ≤ 10μM
|
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.30 |
Binding ≤ 10μM
|
MMP13-2-E |
Matrix Metalloproteinase 13 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.43 |
Binding ≤ 10μM
|
MMP14-2-E |
Matrix Metalloproteinase 14 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
14 |
0.39 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
9 |
0.40 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3100 |
0.28 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3 |
0.43 |
Binding ≤ 10μM
|
Z102240-1-O |
Cartilage (cluster #1 Of 1), Other |
Other |
30 |
0.38 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.49 |
-5.05 |
-25.61 |
2 |
7 |
0 |
101 |
425.89 |
6 |
↓
|
Hi
High (pH 8-9.5)
|
2.49 |
-4.49 |
-67.73 |
1 |
7 |
-1 |
104 |
424.882 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8710 |
0.28 |
Binding ≤ 10μM
|
MMP13-2-E |
Matrix Metalloproteinase 13 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
6 |
0.46 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7 |
0.46 |
Binding ≤ 10μM
|
MMP3-2-E |
Matrix Metalloproteinase 3 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.45 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7200 |
0.29 |
Binding ≤ 10μM
|
MMP8-4-E |
Matrix Metalloproteinase 8 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
11 |
0.45 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
747 |
0.34 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.76 |
6.25 |
-45.85 |
1 |
6 |
-1 |
96 |
362.427 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4540 |
0.22 |
Binding ≤ 10μM
|
MMP13-1-E |
Matrix Metalloproteinase 13 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
38 |
0.31 |
Binding ≤ 10μM
|
MMP14-1-E |
Matrix Metalloproteinase 14 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
91 |
0.29 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
18 |
0.32 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3025 |
0.23 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
10 |
0.33 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.47 |
8.67 |
-62.63 |
1 |
9 |
-1 |
125 |
509.626 |
10 |
↓
|
|
|
|
|
Analogs
-
13916763
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ADA17-2-E |
ADAM17 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
3700 |
0.38 |
Binding ≤ 10μM
|
MMP14-2-E |
Matrix Metalloproteinase 14 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
110 |
0.49 |
Binding ≤ 10μM |
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
14 |
0.55 |
Binding ≤ 10μM |
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
600 |
0.44 |
Binding ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.94 |
-3.19 |
-17.39 |
0 |
3 |
0 |
43 |
306.408 |
5 |
↓
|
|
|
Analogs
-
3976469
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ADA17-2-E |
ADAM17 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
3700 |
0.38 |
Binding ≤ 10μM
|
MMP14-2-E |
Matrix Metalloproteinase 14 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
110 |
0.49 |
Binding ≤ 10μM |
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
14 |
0.55 |
Binding ≤ 10μM |
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
600 |
0.44 |
Binding ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.94 |
6.94 |
-16.83 |
0 |
3 |
0 |
43 |
306.408 |
5 |
↓
|
|
|
Analogs
-
3883169
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 16 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7100 |
0.33 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.40 |
6.63 |
-51.17 |
1 |
5 |
-1 |
86 |
383.243 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ATS4-1-E |
ADAMTS4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4300 |
0.28 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
310 |
0.34 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2000 |
0.30 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2700 |
0.29 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.38 |
9.43 |
-55.2 |
1 |
5 |
-1 |
86 |
380.445 |
7 |
↓
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP12-1-E |
Macrophage Metalloelastase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
320 |
0.31 |
Binding ≤ 10μM
|
MMP13-1-E |
Matrix Metalloproteinase 13 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
120 |
0.33 |
Binding ≤ 10μM
|
MMP14-2-E |
Matrix Metalloproteinase 14 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.29 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
60 |
0.35 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
351 |
0.31 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1300 |
0.28 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.20 |
4.42 |
-55.83 |
2 |
9 |
-1 |
138 |
419.435 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.30 |
6.19 |
-61.75 |
1 |
9 |
-1 |
129 |
431.446 |
6 |
↓
|
|
|
Analogs
-
538656
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP13-4-E |
Matrix Metalloproteinase 13 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
1570 |
0.29 |
Binding ≤ 10μM
|
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
11 |
0.40 |
Binding ≤ 10μM
|
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
91 |
0.35 |
Binding ≤ 10μM
|
MMP3-2-E |
Matrix Metalloproteinase 3 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
134 |
0.34 |
Binding ≤ 10μM
|
MMP3-2-E |
Matrix Metalloproteinase 3 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
7950 |
0.25 |
Binding ≤ 10μM
|
MMP8-4-E |
Matrix Metalloproteinase 8 (cluster #4 Of 4), Eukaryotic |
Eukaryotes |
303 |
0.33 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
301 |
0.33 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3110 |
0.28 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.88 |
2.11 |
-60.39 |
0 |
3 |
-1 |
57 |
409.914 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ADA17-2-E |
ADAM17 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.41 |
Binding ≤ 10μM
|
MMP1-1-E |
Matrix Metalloproteinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8 |
0.40 |
Binding ≤ 10μM
|
MMP13-3-E |
Matrix Metalloproteinase 13 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.43 |
Binding ≤ 10μM
|
MMP14-2-E |
Matrix Metalloproteinase 14 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1 |
0.45 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5 |
0.42 |
Binding ≤ 10μM
|
MMP7-1-E |
Matrix Metalloproteinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
91 |
0.35 |
Binding ≤ 10μM
|
MMP8-1-E |
Matrix Metalloproteinase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
1 |
0.45 |
Binding ≤ 10μM
|
MMP9-1-E |
Matrix Metalloproteinase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
Z80548-1-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
8600 |
0.25 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.69 |
4.53 |
-19.46 |
2 |
8 |
0 |
109 |
423.516 |
5 |
↓
|
Ref
Reference (pH 7)
|
1.87 |
3.33 |
-11.84 |
2 |
8 |
0 |
112 |
423.516 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
1.87 |
4.17 |
-47.82 |
1 |
8 |
-1 |
115 |
422.508 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP1-2-E |
Matrix Metalloproteinase-1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
25 |
0.31 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
41 |
0.30 |
Binding ≤ 10μM
|
MMP3-1-E |
Matrix Metalloproteinase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
157 |
0.28 |
Binding ≤ 10μM
|
MMP9-2-E |
Matrix Metalloproteinase 9 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
25 |
0.31 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.46 |
-2.77 |
-15.67 |
3 |
10 |
0 |
127 |
499.678 |
11 |
↓
|
Hi
High (pH 8-9.5)
|
1.46 |
-3.73 |
-59.76 |
3 |
10 |
-1 |
127 |
498.67 |
11 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 26 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.60 |
14.15 |
-13.35 |
11 |
10 |
0 |
177 |
506.466 |
14 |
↓
|
Ref
Reference (pH 7)
|
3.60 |
15.3 |
-35.73 |
11 |
10 |
1 |
177 |
506.466 |
14 |
↓
|
Hi
High (pH 8-9.5)
|
3.73 |
14.48 |
-12.8 |
11 |
10 |
0 |
174 |
506.466 |
15 |
↓
|
|
|
Analogs
-
578599
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2000 |
0.33 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.38 |
7.37 |
-54.31 |
1 |
5 |
-1 |
86 |
366.846 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
ATS5-1-E |
ADAMTS5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3200 |
0.27 |
Binding ≤ 10μM
|
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2000 |
0.28 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.06 |
9.96 |
-54.51 |
1 |
5 |
-1 |
86 |
414.89 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-1-E |
72 KDa Type IV Collagenase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2000 |
0.28 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.06 |
10.01 |
-45.5 |
1 |
5 |
-1 |
86 |
414.89 |
7 |
↓
|
|